Predictive Oncology IncNASDAQ:POAINASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.7474
- TODAY'S CHANGE (%)0.0584 (8.4761%)
- Bid / Lots0.7447/ 1
- Ask / Lots0.7500/ 5
- Open / Previous Close0.6900 / 0.6890
- Day Range
- 52 Week Range
- Volume40,564
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | POAI |
|---|---|---|
| 09:32 ET | 7852 | 0.69 |
| 09:39 ET | 503 | 0.7051 |
| 10:00 ET | 100 | 0.7051 |
| 10:02 ET | 188 | 0.70735 |
| 10:09 ET | 300 | 0.705876 |
| 10:20 ET | 250 | 0.71 |
| 10:24 ET | 100 | 0.71235 |
| 10:27 ET | 550 | 0.71 |
| 10:36 ET | 150 | 0.72 |
| 10:49 ET | 114 | 0.72 |
| 11:16 ET | 2500 | 0.71 |
| 11:27 ET | 398 | 0.7 |
| 11:39 ET | 100 | 0.71 |
| 11:56 ET | 1000 | 0.7029 |
| 12:03 ET | 125 | 0.7101 |
| 12:28 ET | 650 | 0.701485 |
| 12:32 ET | 125 | 0.70505 |
| 12:42 ET | 255 | 0.7101 |
| 12:51 ET | 500 | 0.71 |
| 01:00 ET | 185 | 0.7101 |
| 01:13 ET | 100 | 0.710099 |
| 01:29 ET | 315 | 0.7051 |
| 01:38 ET | 854 | 0.7051 |
| 01:44 ET | 3000 | 0.7076 |
| 01:45 ET | 200 | 0.7101 |
| 01:54 ET | 100 | 0.7076 |
| 01:58 ET | 301 | 0.7101 |
| 02:00 ET | 2645 | 0.7101 |
| 02:18 ET | 100 | 0.72 |
| 02:20 ET | 4482 | 0.7199 |
| 02:54 ET | 200 | 0.7201 |
| 03:17 ET | 1000 | 0.7299 |
| 03:19 ET | 2000 | 0.7298 |
| 03:26 ET | 2350 | 0.7202 |
| 03:33 ET | 100 | 0.725 |
| 03:35 ET | 200 | 0.7299 |
| 03:37 ET | 1871 | 0.73 |
| 03:39 ET | 1013 | 0.7474 |
Nov 15, 2024
DJ Predictive Oncology Cut to Neutral From Buy by HC Wainwright & Co., from 7:28AM ET on Friday Nov 15, 2024 by Dow Jones
7:28AM ET on Friday Nov 15, 2024 by Dow Jones
Nov 13, 2024
Press Release: Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow JonesPredictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update, from 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Predictive Oncology Inc | 4.6M | -0.3x | --- |
Reflect Scientific Inc | 4.0M | -134.1x | --- |
NAYA Biosciences Inc | 4.3M | -0.3x | --- |
Vycor Medical Inc | 2.9M | -4.8x | --- |
Agape ATP Corp | 6.1M | -2.1x | --- |
Dror Ortho-Design Inc | 4.8M | -1.2x | --- |
Company Information
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples. Pittsburgh segment also develops tumor-specific in vitro models for oncology drug discovery and research. Birmingham segment focuses on contract services and research for biopharmaceutical company clients and academic collaborators, focused on solubility improvements, stability studies, and protein production. Specifically, Birmingham provides optimized formulations for vaccines, antibodies, and other protein therapeutics. Eagan segment produces the STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal.
Contact Information
- Headquarters
- 91 43RD STREET, SUITE 110PITTSBURGH, PA, United States 15201
- Phone
- 412-432-1500
- Fax
- 651-379-5024
Executives
- Chairman of the Board, Chief Executive Officer
- Raymond Vennare
- Interim Chief Financial Officer
- Josh Blacher
- Lead Independent Director
- Chuck Nuzum
- Independent Director
- Nancy Chung-Welch
- Independent Director
- Daniel Handley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.6M |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 6.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.15 |
EPS | $-2.93 |
Book Value | $2.04 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 3.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -960.48% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
